Quinazoline

Quinazoline

SCHEMBL21924844

C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCC1CC2(CCN(C)CC2)C1.c1ccc2ncncc2c1

nearest known ligand 0.86

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 19/20 0.86
▸ ERBB3 P21860 3/20 0.59
▸ DUS2 Q9NX74 1/20 0.59
▸ KDR P35968 2/20 0.57
▸ ERBB2 P04626 9/20 0.57
▸ ERBB4 Q15303 3/20 0.57
▸ KIT P10721 2/20 0.57
▸ SRC P12931 2/20 0.57
▸ STK10 O94804 2/20 0.57
▸ YES1 P07947 2/20 0.57
▸ TEC P42680 2/20 0.57
▸ BTK Q06187 2/20 0.57
▸ SLK Q9H2G2 2/20 0.57
▸ BMPR1B O00238 1/20 0.57
▸ CIT O14578 1/20 0.57
▸ MAP2K7 O14733 1/20 0.57
▸ GAK O14976 1/20 0.57
▸ EPHB6 O15197 1/20 0.57
▸ MAP3K7 O43318 1/20 0.57
▸ RIPK2 O43353 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15090523 0.93 EGFR (1.00) EGFRERBB3DUS2KDRERBB2
SCHEMBL15090691 0.86 EGFR (1.00) EGFRERBB3DUS2KDRERBB2
Hydrochloric Acid SCHEMBL15090716 0.86 EGFR (0.99) EGFRERBB3DUS2KDRERBB2
SCHEMBL15105017 0.86 EGFR (0.86) EGFRERBB2ERBB4SRCGAK
SCHEMBL15090516 0.86 EGFR (0.86) EGFRERBB2ERBB4SRCGAK
SCHEMBL15090527 0.85 EGFR (0.84) EGFRERBB2ERBB4SRCGAK
SCHEMBL15090569 0.85 EGFR (0.84) EGFRERBB2ERBB4SRCGAK
SCHEMBL15090537 0.84 EGFR (1.00) EGFRERBB3DUS2KDRERBB2
Hydrochloric Acid SCHEMBL15104756 0.84 EGFR (0.83) EGFRERBB2ERBB4SRCGAK
Hydrochloric Acid SCHEMBL15090765 0.84 EGFR (0.83) EGFRERBB2ERBB4SRCGAK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3395811-B1 CRYSTALS OF QUINAZOLINE DERIVATIVE AND PREPARATION METHOD THEREFOR XUANZHU PHARMA CO LTD (CN) 2020-05-13 — — EP claimed
Send feedback